Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_assertion type Assertion NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_head.
- NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_assertion description "[ChoK? specific inhibitors, MN58b and TCD-717, have demonstrated a potent antitumoral activity both in vitro and in vivo against several tumor-derived cell line xenografts including CRC-derived cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_provenance.
- NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_assertion evidence source_evidence_literature NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_provenance.
- NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_assertion SIO_000772 23762272 NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_provenance.
- NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_assertion wasDerivedFrom befree-20140225 NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_provenance.
- NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_assertion wasGeneratedBy ECO_0000203 NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_provenance.